Case Report
Published on 02 Jul 2024
Contrast-enhanced ultrasound findings of primary hepatic non-Hodgkin’s lymphoma: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1380392
- 1,116 views
Type at least 3 characters
1,832 articles
Case Report
Published on 02 Jul 2024
The safety and efficacy of the re-administration of gilteritinib in a patient with FLT3-mutated R/R AML with CNS relapse: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1402970
- 1,680 views
- 1 citation
Original Research
Published on 01 Jul 2024
Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1385987
- 1,757 views
Review
Published on 01 Jul 2024
Exploring treatment decision-making in chronic myeloid leukemia in chronic phase
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1369246
- 2,781 views
Review
Published on 01 Jul 2024
Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1394057
- 2,294 views
Mini Review
Published on 28 Jun 2024
Treatment of AL amyloidosis in the era of novel immune and cellular therapies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1425521
- 4,002 views
- 3 citations
Original Research
Published on 25 Jun 2024
Salvage CD20-SD-CART therapy in aggressive B-cell lymphoma after CD19 CART treatment failure
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1376490
- 1,524 views
Mini Review
Published on 25 Jun 2024
Momelotinib – a promising advancement in the management of myelofibrosis in adults with anemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1411972
- 3,013 views
- 1 citation
Review
Published on 24 Jun 2024
Multifaceted roles of IKZF1 gene, perspectives from bench to bedside
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1383419
- 2,627 views
- 1 citation
Original Research
Published on 24 Jun 2024
Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1402992
- 3,121 views
Brief Research Report
Published on 24 Jun 2024
Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1391743
- 1,879 views
- 3 citations
Original Research
Published on 24 Jun 2024
Development and validation of a nomogram to predict poor efficacy of imatinib in the treatment of newly diagnosed chronic phase chronic myeloid leukemia patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1418417
- 892 views
Original Research
Published on 21 Jun 2024
Efficacy and safety analysis of combination therapy based on mitoxantrone hydrochloride liposome injection (Lipo-MIT) in relapsed/refractory NK/T-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1396819
- 1,422 views
- 2 citations
Editorial
Published on 21 Jun 2024
Editorial: The emerging role of liquid biopsies in hematologic disorders
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1437621
- 806 views
Case Report
Published on 20 Jun 2024
Case report: Splenic inflammatory pseudotumor-like follicular dendritic cell sarcoma (IPT-like FDCS): a trial of immunotherapy and review of the literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1360726
- 1,074 views
- 2 citations
Review
Published on 20 Jun 2024
Myelofibrosis and allogeneic transplantation: critical points and challenges
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1396435
- 3,198 views